SGLT-2 inhibitors reduce adverse CV events associated with restenosis in stents in patients with type 2 diabetes.

Published Date: 13 Mar 2023

Italy: Treatment with SGLT2 inhibitors in patients with type 2 diabetes (T2D) is associated with a reduced risk of restenosis in the stent...

Read Full News

Latest News

GLP-1 Era Demands a New Model of Obesity Care

Panelists at HLTH Europe 2026 say obesity care must shift to lifelong digital models and shed its stigma as a moral failing.

Erosive Hand OA Flags Fracture Risk in Postmenopausal Women

Erosive hand osteoarthritis is associated with an increased risk for incident osteoporotic fractures in postmenopausal women, a study finds.

Medicare to Cover New Osteoporosis Diagnostic Screening Test

Medicare coverage of a new osteoporosis screening tool may help to address the challenge of identifying and treating patients with osteoporosis by expanding access to screening.

10-Hour Eating Window Boosts Weight Loss in Obesity

10-hour time-restricted eating promotes greater weight loss and improved body composition in adults with obesity and without diabetes than standard dietary counseling alone.

US Health Department Proposes Testosterone Therapy Label Updates

The U.S. health department said on Thursday it was seeking updates to labels for testosterone replacement therapies after reviewing new clinical data ⁠and other...

The HPV Vaccine at 20: Progress Made, Challenges Ahead

Evidence supports HPV vaccination as a powerful cancer prevention tool, but improving its uptake remains critical for achieving long-term public health goals.

Todays Updates

FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug

The U.S. Food and Drug Administration has declined to approve Achieve Life Sciences' drug to treat nicotine dependence in adults, ⁠citing unresolved issues found at a...

The New Perfectionism Problem in Medical Training

The profession has always attracted perfectionists. Experts worry a more fear-based version of the trait could affect both doctors and patients.

Rucaparib Delays Next Lines of Therapy in Ovarian Cancer

Rucaparib maintenance delays both first and second subsequent therapies among patients with advanced ovarian cancer.

Todays Updates

FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug

The U.S. Food and Drug Administration has declined to approve Achieve Life Sciences' drug to treat nicotine dependence in adults, ⁠citing unresolved issues found at a...

The New Perfectionism Problem in Medical Training

The profession has always attracted perfectionists. Experts worry a more fear-based version of the trait could affect both doctors and patients.

Rucaparib Delays Next Lines of Therapy in Ovarian Cancer

Rucaparib maintenance delays both first and second subsequent therapies among patients with advanced ovarian cancer.

Latest News

Panelists at HLTH Europe 2026 say obesity care must shift to lifelong digital models and shed its stigma as a moral failing.

Erosive hand osteoarthritis is associated with an increased risk for incident osteoporotic fractures in postmenopausal women, a study finds.

Medicare coverage of a new osteoporosis screening tool may help to address the challenge of identifying and treating patients with osteoporosis by expanding access to screening.

10-hour time-restricted eating promotes greater weight loss and improved body composition in adults with obesity and without diabetes than standard dietary counseling alone.

The U.S. health department said on Thursday it was seeking updates to labels for testosterone replacement therapies after reviewing new clinical data ⁠and other...

Evidence supports HPV vaccination as a powerful cancer prevention tool, but improving its uptake remains critical for achieving long-term public health goals.

News All Time

Support Groups Boost Weight Loss in Patients With Obesity

Consistent engagement in a support group paired with lifestyle changes has been shown to be linked to notably greater weight loss in a community gastroenterology clinic weight-management program.

GLP-1s Tied to Lower Cancer Risk in Patients With Obesity

In a large observational study of adults with obesity without diabetes, GLP-1 receptor agonists were associated with a 41% lower incidence of obesity-associated cancers over 2 years.

German Government to Abandon Variable Drug Discounting Plans, Source Tells Reuters

Germany's government is replacing plans that would have introduced variable discounts on pharmaceuticals, ⁠a government source told Reuters on Monday, following opposition...

Male Fertility Not Harmed by GLP-1s and Maybe Helped

A systematic review finds no consistent adverse effects on the male hypothalamic-pituitary-gonadal axis and some evidence of fertility improvement with GLP-1 use.

Tirzepatide May Reverse Postbariatric Weight Regain

Tirzepatide treatment yields substantial weight loss and is well tolerated in patients with recurrent weight gain after bariatric procedures, a small real-world observational study finds.

Distinct Courses in Primary and Secondary Empty Sella

Patients with primary and secondary empty sella show distinct clinical and endocrine trajectories over a median follow-up of about 5 years.

Does Tirzepatide Activate Brown Fat?

Tirzepatide seems to activate brown adipose tissue, potentially modulating energy expenditure at the tissue level in premenopausal women with obesity.

Semaglutide Linked to Fewer Fractures

In contrast to concerns of lean mass loss with GLP-1 receptor agonists, a large population-based study found lower fracture rates with semaglutide than with other weight-loss medications.

Novel Monoclonal Antibody Shows Benefit in Cushing Disease

The anti-adrenocorticotropic hormone antibody asedebart normalized urinary free cortisol in 7 of 8 study participants.

GLP-1s Aren’t a Solo Act. They Need Comprehensive Planning

Lifestyle changes, tracking, and support should go hand-in-hand with weight loss drugs.

AI Eye Scan Cuts Unneeded Diabetes Macular Edema Referrals

An AI-based OCT system integrated into standard diabetic retinopathy screening pathways reduces unwarranted referrals for diabetic macular edema, a recent study shows.

Neumora Scraps Depression Drug Development After Repeated Trial Failures

Neumora Therapeutics will abandon the development of its experimental depression drug following the latest trial failures and ⁠said it would cut 35% of its workforce,...

Chronic Opioid Use Raises Risk for Endocrinopathies

Possible complications include adrenal insufficiency, hypogonadism, hyperprolactinemia, hospitalization, and mortality.

Teplizumab Approved for Pediatric Stage 3 Type 1 Diabetes

The drug was previously approved for stage 2 T1D.

Encaleret Shows Rapid Response in ADH1

The oral modulator of the calcium-sensing receptor targets the causes of ADH1, significantly improving serum and urine calcium levels.

Testosterone Prescribing Often Ignores Guidelines

Only 12% of patients prescribed testosterone underwent appropriate diagnostic testing, and overprescribing was common in a single-center US study.

Recommended News For You

GFR-TKIs taken orally in cancer patients who have artery dissection and aneurysms.

FDA Approves New Bladder Cancer First-Line Standard of Care.

Top Options Are Discovered Through Direct Comparison of 25 Migraine Drugs.

Pain’s Toll: Frailty Risk for Childhood Cancer Survivors

Pulled Myeloma Drug Improves Survival in Trial

New research uncovers link between cancer pathway and blood-retina barrier function

Early-life exposure to air and light pollution linked to increased risk of pediatric thyroid cancer

Recommended Articles For You

The Life-Saving Powers of Anemia: How to Combat the Disease. 

Personalized Cancer Vaccines and Neoantigen mRNA: A New Era in Oncology 

Transformative Practices in Hematology and Quality Improvement 

Introduction to Immune Thrombocytopenic Purpura 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Bladder cancer link to explosive ordnance exposure among Army veteran bomb disposal officers

2.

Transplantation Fails to Improve Survival in Mantle Cell Lymphoma

3.

Potentially Novel Approach for Treating Advanced Colorectal Cancer with KRAS Mutations.

4.

Small-Town Patients Face Big Hurdles as Rural Hospitals Cut Cancer Care

5.

Weight loss and cancer; no brain tumor blood test; no cervical cancer after HPV vaccination.

1.

Mechanistic Depth and Clinical Impact of Rusfertide, Onyvide, IV Avastin, and Pemfexy

2.

Optimizing Oncology Practice Revenue: Billing Software, Payer Trends, and Financial Navigation Tools

3.

Contemporary Pathways in Hematology and Patient Outcomes

4.

Clinical Methods in Hematology and Quality Improvement

5.

Metabolic Competition Within the Tumor Ecosystem: Mechanisms, Clinical Relevance, and Therapeutic Advances

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Thromboprophylaxis In Medical Settings- An Update

2.

Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC

3.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II

4.

Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Summarization of the New Perspective

5.

Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot